Discover 1,973 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,973
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
for
Metastatic Breast Cancer
Location: Plantation FL, Miami FL, Jacksonville FL, Atlanta GA,
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
for
Asthma
Location: Plantation FL, Brooksville FL, Philadelphia PA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06979323
Phase 3, Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
for
Endometrial Cancer
Location: Plantation FL, Doral FL, Miami FL, North Miami FL,
Sponsor: Canadian Cancer Trials Group
Sex: Female
Age: 18+
Code: NCT05640999
Phase 2, Recruiting
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Plantation FL, North Miami FL, Doral FL,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT05646316
Phase 3, Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Plantation FL, Aventura FL, North Miami FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase 1, Phase 2, Recruiting
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer